FTAI outlines $2.3B 2027 adjusted EBITDA target as it launches $500M ASR
Read original article on Breaking News on Seeking Alpha →Related news
-
FDA draft guidance aims to speed personalized gene therapies for rare diseases
Health
Medicine
United States
- Provident Financial expects 5%-6% full year loan and deposit growth as it models a December 2026 Fed hike Economy Personal Finance United Kingdom
- Pediatrix narrows 2026 adjusted EBITDA outlook to $290M-$300M as buybacks reach 10M shares Business Corporate United States
- Invitation Homes outlines $1.94-$1.98 2026 core FFO per share guidance while expanding $500M buyback authorization Business Real Estate United States
- Newmark forecasts $3.7B-$3.8B 2026 revenue amid revised outlook and CEO transition Business Corporate United States
-
GFL Environmental gains on report sovereign joins bidding
Business
Corporate
-
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Economy
Markets
-
After 30 Years, Skillet Keeps Reaching New Fans. Here’s How
Entertainment
Music
United States